All Infectious Disease articles – Page 6
-
NewsInfluenza virus hacks cell’s internal system
The influenza virus manipulates the body’s gene regulation system to accelerate its own spread, according to researchers. Their study shows that an already approved drug could help strengthen immune defenses—though its effect in humans remains to be confirmed.
-
NewsAntibiotic resistance: Towards drugs to disarm bacteria
Researchers have identified the mutation frequency decline (Mfd) protein, a virulence factor produced by all bacteria and essential for them to resist the host immune system. This protein has the additional function of promoting spontaneous and random mutations.
-
NewsEuropean Immunization Week 2025: Inequalities in immunisation against measles could contribute to outbreaks
Research reveals inequalities in MMR vaccination that may contribute to measles outbreaks and epidemics, emphasising the importance of socioeconomic and demographic data in driving public health efforts.
-
NewsTick researchers identify new strain of rickettsia bacteria that causes spotted fever infections in humans
In a residential backyard in Maine, researchers stumbled upon a surprise finding: rabbit ticks harboring a new type of bacteria related to a group of pathogens that can cause sometimes life-threatening spotted fever rickettsioses (SFR) infections in humans.
-
NewsHospital-based outbreak detection system saves lives
An infectious diseases detection platform has proved over a two-year trial that it stops outbreaks, saves lives and cuts costs. The results make the case for adoption in hospitals nationwide and the development of a national early outbreak detection database.
-
NewsGlobal study finds single-dose baloxavir reduces household influenza transmission
A landmark study reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of influenza within households, marking a major advancement in influenza management.
-
NewsAtomic imaging and AI offer new insights into motion of parasite behind sleeping sickness
Researchers applied leading-edge atomic imaging and AI-driven modeling to create the most detailed 3D map yet of the flagellum on Trypanosoma brucei, which causes sleeping sickness.
-
NewsTransatlantic collaboration to develop therapeutic for Crimean-Congo Hemorrhagic Fever
A new transatlantic collaboration will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally.
-
NewsInfectious disease surveillance platform BEACON launches as a new open-source global resource
The Biothreats Emergence, Analysis and Communications Network (BEACON), an open-source infectious diseases monitoring tool powered by AI and human experts, has been launched.
-
NewsSugar-mimicking molecule central to virulence of a common crop disease, study finds
A strain of Pseudomonas syringae manipulates plants by producing a substance called glycosyrin to suppress the immune response. New research shows that glycosyrin does this by mimicking galactose, acting like a wolf in sheep’s clothing.
-
NewsAntibiotic-resistant Escherichia albertii on the rise in Bangladeshi chicken shops
Researchers have detected alarming rates of Escherichia albertii in retail chicken meat in Bangladesh. Their findings show extensive contamination and significant antimicrobial resistance, underscoring the potential risks to public health.
-
NewsThe very first structural images of a tuberculosis-fighting virus
Scientists have used advanced imaging techniques to provide a detailed look at how a tiny virus, known as a phage, invades Mycobacteria. The research could pave the way toward phage-based treatments for antibiotic-resistant mycobacteria.
-
NewsExperts stress importance of vaccination amidst measles outbreaks
Pediatric infectious diseases experts stress the importance of vaccination against measles, one of the most contagious viruses, which is once more spreading in the United States.
-
NewsStudy of oral azvudine versus nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients
A study used five analytical methods to show that oral azvudine has a therapeutic effect in elderly COVID-19 patients aged over 60 years.
-
NewsPotential first new antibiotic for gonorrhoea since the 1990s is effective and safe, finds trial
Gepotidacin could be a new treatment to treat gonorrhoea, protecting against the threat of treatment-resistant gonorrhoea and improving patient treatment experiences, suggests the results of a phase 3 randomised control trial.
-
NewsOropouche virus infections underestimated in Latin America and likely to increase due to climate factors
Environmental factors, such changing temperatures and rainfall, are the main drivers associated with the spread of Oropouche virus (OROV) in Latin America, according to a modelling study.
-
NewsPatients with multi drug-resistant cholera in Europe linked to exposure to contaminated holy water from Ethiopia
Exposure to holy water from Ethiopia has recently been linked to several cases of cholera in the UK and Germany with a multidrug-resistant Vibrio cholerae strain, according to a new study.
-
NewsDeadly rodent-borne hantavirus is an emerging disease with pandemic potential
Researchers have found three hotspots of hantavirus circulation in wildlife in the US – Virginia, Colorado, and Texas – and identified 15 rodent species as carriers, including six species that had not previously been identified as hosts of the virus.
-
NewsDogs could help predict valley fever spread in humans
Valley fever, or coccidioidomycosis, is caused by a fungus that thrives in moist soils and becomes airborne during drought. In a new study, researchers show that dogs, who are also susceptible to the disease, can help us understand its spread.
-
NewsStudies shows new class of antibiotic is effective in tackling MRSA
New research has shown a daily dose of epidermicin NI01 – an antibiotic compound developed by University of Plymouth spinout company Amprologix – is as effective at removing Methicillin-resistant Staphylococcus aureus (MRSA) as the current standard of care.